Explore Targets

Theralink → Explore Targets

Death-Receptor-Signaling1

NFkB-Pathway1

NFkB_Pathway

Pathways created with BioRender.com

Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4
Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board
Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company